Literature DB >> 18216006

Etiology and treatment of community-associated methicillin-resistant Staphylococcus aureus.

Ronald A Herman1, Vicki R Kee, Kevin G Moores, Mary B Ross.   

Abstract

PURPOSE: Risk factors and treatment recommendations for community-associated methicillin-resistant Staphylococcus aureus are reviewed.
SUMMARY: A new strain of methicillin-resistant Staphylococcus aureus (MRSA) has prompted researchers to examine the factors associated with infections acquired in outpatient settings as opposed to those that develop nosocomially. Infections of the skin, lungs, urinary tract, and bloodstream diagnosed within 24-72 hours of hospitalization and with no risk factors present were categorized as community-associated MRSA (CA-MRSA) and differentiated from health-care-associated methicillin-resistant S. aureus (HA-MRSA) on a molecular basis. Pulsed-field electrophoresis has been instrumental in genotyping the S. aureus organism to identify bacterial isolates. Molecular differences between community- and hospital-associated strains show that the organisms were genetically distinct and had not migrated to other settings. Some studies examining antibiotic resistance indicated a steady increase in the rate of MRSA infections. In addition, results of a 15-year longitudinal study indicated significant increases in CA-MRSA-positive isolates between 1991 and 2004. Race, age, sex, hygiene, living environment, and socioeconomic status have been shown to play a key role in the incidence of CA-MRSA.
CONCLUSION: Health care providers should recognize how CA-MRSA and HA-MRSA are differentiated and what factors are associated with infections caused by the organisms. This will enable health care providers to quickly identify and initiate appropriate treatment for these infections.

Entities:  

Mesh:

Year:  2008        PMID: 18216006     DOI: 10.2146/ajhp060637

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.637


  7 in total

Review 1.  Predictors of mortality in Staphylococcus aureus Bacteremia.

Authors:  Sebastian J van Hal; Slade O Jensen; Vikram L Vaska; Björn A Espedido; David L Paterson; Iain B Gosbell
Journal:  Clin Microbiol Rev       Date:  2012-04       Impact factor: 26.132

2.  Public health surveillance for methicillin-resistant Staphylococcus aureus: comparison of methods for classifying health care- and community-associated infections.

Authors:  Dawn M Sievert; Mark L Wilson; Melinda J Wilkins; Brenda W Gillespie; Matthew L Boulton
Journal:  Am J Public Health       Date:  2010-07-15       Impact factor: 9.308

3.  Filaments in curved streamlines: Rapid formation of Staphylococcus aureus biofilm streamers.

Authors:  Minyoung Kevin Kim; Knut Drescher; On Shun Pak; Bonnie L Bassler; Howard A Stone
Journal:  New J Phys       Date:  2014-06-26       Impact factor: 3.729

4.  Relevant role of fibronectin-binding proteins in Staphylococcus aureus biofilm-associated foreign-body infections.

Authors:  Marta Vergara-Irigaray; Jaione Valle; Nekane Merino; Cristina Latasa; Begoña García; Igor Ruiz de Los Mozos; Cristina Solano; Alejandro Toledo-Arana; José R Penadés; Iñigo Lasa
Journal:  Infect Immun       Date:  2009-07-06       Impact factor: 3.441

5.  Methicillin-resistant Staphylococcus aureus: an overview for manual therapists().

Authors:  Bart N Green; Claire D Johnson; Jonathon Todd Egan; Michael Rosenthal; Erin A Griffith; Marion Willard Evans
Journal:  J Chiropr Med       Date:  2012-03

6.  Impact of ethnicity and socio-economic status on Staphylococcus aureus bacteremia incidence and mortality: a heavy burden in Indigenous Australians.

Authors:  Steven Y C Tong; Sebastian J van Hal; Lloyd Einsiedel; Bart J Currie; John D Turnidge
Journal:  BMC Infect Dis       Date:  2012-10-09       Impact factor: 3.090

7.  Nasal carriage screening of community-associated methicillin resistant Staphylococcus aureus in healthy children of a developing country.

Authors:  Sina Mobasherizadeh; Hasan Shojaei; Seyed Asghar Havaei; Kamyar Mostafavizadeh; Fazlollah Davoodabadi; Farzin Khorvash; Ali Mehrabi Kushki; Abbas Daei-Naser; Fahimeh Ghanbari
Journal:  Adv Biomed Res       Date:  2016-08-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.